Tuberculosis treatment outcome monitoring in European Union countries: systematic review.
Tuberculosis treatment outcome monitoring in European Union countries: systematic review.
复制标题
欧盟国家的结核病治疗结果监测：系统评价。
DOI：
10.1183/09031936.00030612
复制
发表时间：
2013-03
期刊：
影响因子：
--
通讯作者：
de Vries G
中科院分区：
文献类型：
--
作者：
van Hest R;Ködmön C;Verver S;Erkens CG;Straetemans M;Manissero D;de Vries G
通过治疗结果监测（TOM）衡量的治疗成功率是结核病控制规划的一项关键规划产出。我们对30个欧盟（EU）/欧洲经济区（EEA）国家的国家级TOM进行了系统的文献综述，以总结用于收集和报告TOM数据的方法。检索在线参考书目数据库PubMed/MEDLINE和EMBASE，以识别2000年1月至2010年8月期间发表的相关索引和非索引文献。检索策略导致615个潜在相关的索引引文，其中27个全文国家研究（79个数据集）被纳入最终分析。选定的研究在10个欧盟/欧洲经济区国家进行，并给出了欧盟/欧洲经济区TOM的碎片化印象。发表年份、研究周期、样本量、数据库、定义、变量、患者和结局类别以及人群亚组差异很大，描绘了一幅非常异质的画面。该综述证实了之前关于EU/EEA国家TOM结果出版物存在相当大异质性的报告。PubMed/MEDLINE和EMBASE索引研究不是测量30个EU/EEA国家代表性TOM结果的合适工具。统一和完整地向欧洲中央监测系统报告将产生欧盟/欧洲经济区最及时和最可靠的结核病治疗结果。
Treatment success measured by treatment outcome monitoring (TOM) is a key programmatic output of tuberculosis (TB) control programmes. We performed a systematic literature review on national-level TOM in the 30 European Union (EU)/European Economic Areas (EEA) countries to summarise methods used to collect and report data on TOM. Online reference bibliographic databases PubMed/MEDLINE and EMBASE were searched to identify relevant indexed and non-indexed literature published between January 2000 and August 2010. The search strategy resulted in 615 potentially relevant indexed citations, of which 27 full-text national studies (79 data sets) were included for final analysis. The selected studies were performed in 10 EU/EEA countries and gave a fragmented impression of TOM in the EU/EEA. Publication year, study period, sample size, databases, definitions, variables, patient and outcome categories, and population subgroups varied widely, portraying a very heterogeneous picture. This review confirmed previous reports of considerable heterogeneity in publications of TOM results across EU/EEA countries. PubMed/MEDLINE and EMBASE indexed studies are not a suitable instrument to measure representative TOM results for the 30 EU/EEA countries. Uniform and complete reporting to the centralised European Surveillance System will produce the most timely and reliable results of TB treatment outcomes in the EU/EEA.
登录
查看更多内容
影响因子：
5.8
作者：
Caylà JA;Rodrigo T;Ruiz-Manzano J;Caminero JA;Vidal R;García JM;Blanquer R;Casals M;Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE)
通讯作者：
Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE)
影响因子：
24.3
作者：
Broekmans, JF;Migliori, GB;Raviglione, MC
通讯作者：
Raviglione, MC
影响因子：
24.3
作者：
Kliiman, K.;Altraja, A.
通讯作者：
Altraja, A.
影响因子：
10
作者：
Abubakar, I.;Moore, J.;Watson, J. M.
通讯作者：
Watson, J. M.
影响因子：
3.7
作者：
Johnston JC;Shahidi NC;Sadatsafavi M;Fitzgerald JM
通讯作者：
Fitzgerald JM